TOP TEN perturbations for 39255_at (Homo sapiens)
Organism: Homo sapiens
Gene: 39255_at
Selected probe(set): 206259_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 39255_at (206259_at) across 6674 perturbations tested by GENEVESTIGATOR:
Langerhans cell histiocytosis study 1 / normal plasmocytoid dendritic cell sample
Relative Expression (log2-ratio):-3.5530138Number of Samples:7 / 3
Experimental | Langerhans cell histiocytosis study 1 |
Langerhans cell histiocytes (LCH) were isolated from LCH lesions of patients undergoing surgery. All patients had single system disease, five patients had bone lesion, one had skin lesion and one had mucosal manifestation. Langerhans cells histiocytes were purified by FACS as CD1a+ / CD270 + population with > 95% purity. | |
Control | normal plasmocytoid dendritic cell sample |
Normal plasmocytoid dendritic cells were isolated from peripheral blood of healthy adult donors. Plasmocytoid dendritic cells were defined as HLA-DR+ / CD45RAhi / CD11c- / BDCA2+ population. |
Hep-G2 / HepaRG
Relative Expression (log2-ratio):3.1178093Number of Samples:9 / 12
Experimental | Hep-G2 |
Human primary cancer cell line derived from the liver of a patient with hepatocellular carcinoma. Synonyms:HEP-G2; Hep G2; HEP G2; HepG2; HEPG2 Cellosaurus code: | |
Control | HepaRG |
Immortalized cancer cell line derived from female patient with hepatocellular carcinoma. Cells can be induced to differentiate into hepatocyte-like cells by exposure to DMSO. Synonyms:Hepa-RG Cellosaurus code: |
dendritic cell study 6 (gardiquimod; RN486) / dendritic cell study 6 (untreated)
Relative Expression (log2-ratio):-2.934204Number of Samples:4 / 8
Experimental | dendritic cell study 6 (gardiquimod; RN486) |
Plasmacytoid dendritic cells (pDCs) collected from blood of healthy donors and treated with gardiquimod (TLR7 agonist) and RN486 (Bruton’s tyrosine kinase; BTK inhibitor) for 3 hours. pDCs were sorted as CD303+, CD123+, CD45+, CD69+, CD40+, CD86+. | |
Control | dendritic cell study 6 (untreated) |
Plasmacytoid dendritic cells (pDCs) collected from blood of healthy donors. pDCs were sorted as CD303+, CD123+, CD45+, CD69+, CD40+, CD86+. |
dendritic cell study 6 (gardiquimod) / dendritic cell study 6 (untreated)
Relative Expression (log2-ratio):-2.499896Number of Samples:7 / 8
Experimental | dendritic cell study 6 (gardiquimod) |
Plasmacytoid dendritic cells (pDCs) collected from blood of healthy donors and treated with gardiquimod (TLR7 agonist) for 3 hours. pDCs were sorted as CD303+, CD123+, CD45+, CD69+, CD40+, CD86+. | |
Control | dendritic cell study 6 (untreated) |
Plasmacytoid dendritic cells (pDCs) collected from blood of healthy donors. pDCs were sorted as CD303+, CD123+, CD45+, CD69+, CD40+, CD86+. |
HCC study 23 (portal vein infiltration) / adjacent liver tissue
Relative Expression (log2-ratio):-2.3296852Number of Samples:3 / 10
Experimental | HCC study 23 (portal vein infiltration) |
Tumor liver tissue samples derived from patients with hepatocellular carcinoma (HCC) with portal vein infiltration. Samples were derived by laser capture microdissection (LCM) from patients with HCC from the Chinese National Human Genome Center at Shanghai. | |
Control | adjacent liver tissue |
Normal adjacent liver tissue samples derived from patients with hepatocellular carcinoma (HCC). Samples were derived by laser capture microdissection (LCM) from patients with HCC from the Chinese National Human Genome Center at Shanghai. |
clear cell renal cell carcinoma study 4 (stage 3) / normal kidney tissue
Relative Expression (log2-ratio):-2.2891064Number of Samples:14 / 69
Experimental | clear cell renal cell carcinoma study 4 (stage 3) |
Primary tumor tissue from patients with stage 3 clear cell renal cell carcinoma (ccRCC). | |
Control | normal kidney tissue |
Normal kidney tissue samples obtained from healthy individuals. |
AsPC-1 / BxPC-3
Relative Expression (log2-ratio):2.2791376Number of Samples:3 / 3
Experimental | AsPC-1 |
Human xenograft derived metastatic cancer cell line derived from mouse xenografts initiated with metastatic cells from the ascites derived from a 62 years old female Caucasian patient with pancreatic adenocarcinoma. Synonyms:AsPc-1; Aspc-1; ASPC-1; As-PC1; ASPC1; AsPC1; Aspc1; AsPc1 Cellosaurus code: | |
Control | BxPC-3 |
Human pancreatic adenocarcinoma cell line derived from a 61 years old female patient. Synonyms:BxPc-3; BXPC-3; Bx-PC3; BXPC3; BxPC3; BxPc3 Cellosaurus code: |
clear cell renal cell carcinoma study 4 (stage 1) / normal kidney tissue
Relative Expression (log2-ratio):-2.2721329Number of Samples:23 / 69
Experimental | clear cell renal cell carcinoma study 4 (stage 1) |
Primary tumor tissue from patients with stage 1 clear cell renal cell carcinoma (ccRCC). | |
Control | normal kidney tissue |
Normal kidney tissue samples obtained from healthy individuals. |
TGF-ß study 9 / untreated PANC-1 cell sample
Relative Expression (log2-ratio):2.2682457Number of Samples:3 / 3
Experimental | TGF-ß study 9 |
PANC-1 cells were grown to 70% confluency. Thereafter the cells were cultured for one day in serum-free conditions and then incubated for 48 hours with fresh media containing 5nM TGF-ß. Before harvesting, cells were washed 3x with PBS and lysed by direct addition of TRIzol reagent for RNA extraction. | |
Control | untreated PANC-1 cell sample |
PANC-1 cells were grown to 70% confluency. Thereafter the cells were cultured for one day in serum-free conditions and then incubated for 48 hours with plain fresh media. Before harvesting, cells were washed 3x with PBS and lysed by direct addition of TRIzol reagent for RNA extraction. |
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone study 1 (10000 uM; Hep-G2) / vehicle (PBS) treated Hep-G2 cell sample
Relative Expression (log2-ratio):-2.2036476Number of Samples:3 / 6
Experimental | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone study 1 (10000 uM; Hep-G2) |
Hep-G2 cells exposed to 10000 uM 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (dissolved in PBS) for 72 hours. Cells were exposed to the chemical when 80% confluence was reached. Cells were treated with the IC10 determined by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test (number of replicates, n = 3). ATC code:--- | |
Control | vehicle (PBS) treated Hep-G2 cell sample |
Hep-G2 cells treated with vehicle (PBS) for 72 hours. Cells were exposed to the vehicle when 80% confluence was reached. |